McKesson Corporation (MCK)
| Market Cap | 29.61B |
| Revenue (ttm) | 234.19B |
| Net Income (ttm) | 2.23B |
| Shares Out | 162.00M |
| EPS (ttm) | 13.03 |
| PE Ratio | 14.15 |
| Forward PE | 10.44 |
| Dividend | $1.68 |
| Dividend Yield | 0.91% |
| Trading Day | January 15 |
| Last Price | $184.42 |
| Previous Close | $184.42 |
| Change ($) | 0.00 |
| Change (%) | 0.00% |
| Day's Open | 182.32 |
| Day's Range | 179.55 - 185.48 |
| Day's Volume | 901,764 |
| 52-Week Range | 114.86 - 185.48 |
McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.
Here we discuss four dividend-paying value stocks, MCK, CAH, BDX and HRC, which though trading cheap now, have solid chances of a rebound in the second half of 2021.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) will release its third quarter fiscal 2021 financial results before market open on Tuesday, February 2, 2021. The company will h...
Here we discuss five GARP stocks, TAP, OMI, TD, MCK and HMC, which while trading cheap at this moment, are generating robust growth rates on strong fundamentals.
As I stated last week, the healthcare sector is one of my favorite sectors to find recession proof companies. Consumers will, to the best of their abilities, seek out treatments for what ails ...
McKesson Corp., the giant health care distributor selected by the U.S. government to manage logistics for the COVID-19 vaccine immunization campaign, on Sunday began pushing out millions of do...
IRVING, Texas--(BUSINESS WIRE)--McKesson Fills Initial Government Orders for Moderna's COVID-19 Vaccine
Optimism on the progress of stimulus talks sent markets to more mild gains. After markets closed at record highs on Thursday, stimulus hopes sent markets higher again.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
With 2020 almost over and the new year just two short weeks away, many investors are resetting for what could be a volatile 2021.
McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.
Let's see if McKesson Corp (MCK) stock is a good choice for value-oriented investors right now from multiple angles.
One medical distribution company has been through this before.
Amazon.com Inc. (NASDAQ:AMZN) has been one of the most innovative and disruptive companies of this century, with incredible success in areas that lie outside of what has been historically perc...
McKesson (MCK) reported earnings 30 days ago. What's next for the stock?
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation today announced the launch of Ontada, an oncology technology and insights business designed to support innovation, acceleration, and eviden...
Demonstrating effectiveness is no small task, but the next challenge may be even greater.
Excited about the Covid-19 vaccines from Pfizer and Moderna? You'll be waiting a long time unless the vaccines can be shipped at 94 degrees below zero.
McKesson's share price has reacted negatively on news of Amazon's entry into the pharmacy space. I see this reaction as being unwarranted. Meanwhile, McKesson continues to show operating stren...
McKesson shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. The post Health Care Products Giant McKesson Earns Key Rating Upgrade appeared first on Inve...
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) today announced that the company has appointed Dr. Kelvin A. Baggett to the newly created role of chief impact officer, effectiv...
Cramer delivers thoughts on vaccine distribution plays
The "Mad Money" host explained why he's recommending the stocks of Carrier, McKesson and CVS Health to investors looking to get exposure to vaccine logistics.
Optimism about effective vaccines coming soon have sent the market back to record highs, ending the pullback. For the rest of the year, the pandemic is expected to continue getting worse. JPMo...
McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.
McKesson Corporation (MCK) CEO Brian Tyler on Q2 2021 Results - Earnings Call Transcript
McKesson, which the U.S. government has tabbed to distribute the Covid-19 vaccines, posted quarterly earnings that easily topped views and hiked its earnings outlook, and MCK stock rose. The p...
McKesson Corporation's (MCK) CEO Brian Tyler on Q2 2021 Results - Earnings Call Transcript
McKesson's (MCK) fiscal second-quarter 2021 results benefit from strong segmental performance.
McKesson Corp said on Tuesday it and two other drug distributors could be expected pay up to $21 billion for the potential settlement of lawsuits alleging they fueled the U.S. opioid epidemic.
McKesson (MCK) delivered earnings and revenue surprises of 24.03% and 2.50%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of McKesson Corp. gained 3.99% in premarket trading on Tuesday after it beat earnings expectations for the quarter. The drug distributor had earnings of $627 million, or $3.54 per share...
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) today reported results for the second quarter ended September 30, 2020. Fiscal 2021 Second-Quarter Result Summary Second-Qua...
DEERFIELD, Ill. & IRVING, Texas--(BUSINESS WIRE)--Walgreens Boots Alliance and McKesson announce the completion of their agreement to create a German wholesale joint venture.
International sales accounted for 59 percenDaily Dividend Report: Apple, Capital One Financial, Yamana Gold, AbbVie, Walgreens Boots Alliance, McKessont of the quarter's revenue.
McKesson's (MCK) fiscal second-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions segment.
IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 42 cents per share of common stock. The dividend will be paya...
3 Dental Supplies Stocks Set to Shine on the Industry's Upturn
In this article we will check out the progression of hedge fund sentiment towards McKesson Corporation (NYSE:MCK) and determine whether it is a good investment right now. We at Insider Monkey ...
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) today announced that the McKesson board of directors has elected Linda Mantia as an independent director and member of the boar...
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK) will release its second quarter fiscal 2021 financial results before market open on Tuesday, November 3, 2020. The company will ...
Let's keep a watch on potentially strong three stocks in the dental space that have shown promise during the pandemic.
SAN FRANCISCO--(BUSINESS WIRE)--McKesson Ventures, the venture capital arm of McKesson Corporation, announces the expansion of its leadership team, promoting Jennifer Carter and Carrie Hurwitz...
Stocks have made a remarkable (and remarkably rapid) recovery from the 2020 bear market.
McKesson (MCK) reported earnings 30 days ago. What's next for the stock?
About MCK
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment provides practice management, technology, clinical support, and business solutions to community-based oncology and other spe... [Read more...]
| Industry Medical Distribution | Founded 1833 |
| CEO Brian Tyler | Employees 60,000 |
| Stock Exchange NYSE | Ticker Symbol MCK |
Financial Performance
In 2019, McKesson's revenue was $231.05 billion, an increase of 7.81% compared to the previous year's $214.32 billion. Earnings were $900.00 million, an increase of 2,547.06%.
Analyst Forecasts
According to 19 analysts, the average rating for McKesson stock is "Buy." The 12-month stock price forecast is 201.69, which is an increase of 9.36% from the latest price.